TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BioNema AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,237
|
2,545
|
3,481 |
| Financial expenses |
2
|
5
|
1 |
| Earnings before taxes |
314
|
328
|
1,085 |
| EBITDA |
376
|
424
|
1,179 |
| Total assets |
2,441
|
2,275
|
2,620 |
| Current assets |
2,008
|
1,808
|
2,062 |
| Current liabilities |
306
|
194
|
498 |
| Equity capital |
2,135
|
2,081
|
2,005 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
87.5%
|
91.5%
|
76.5% |
| Turnover per employee |
1,618
|
1,272
|
1,740 |
| Profit as a percentage of turnover |
9.7%
|
12.9%
|
31.2% |
| Return on assets (ROA) |
12.9%
|
14.6%
|
41.5% |
| Current ratio |
656.2%
|
932.0%
|
414.1% |
| Return on equity (ROE) |
14.7%
|
15.8%
|
54.1% |
| Change turnover |
692
|
-936
|
-255 |
| Change turnover % |
27%
|
-27%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.